Pharmaceutical Product Development, Inc.Wilmington, NC, United States (NASDAQ (GS): PPDI)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Pharmaceutical Product Development Financial Statements

Pharmaceutical Product Development Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Pharmaceutical Product Development Income Statement

  2007 2006 2005
Revenue ($ mil.) 1,414.5 1,247.7 1,037.1
Gross Profit ($ mil.) 642.9 577.2 493.8
Operating Income ($ mil.) 230.0 220.0 194.6
Total Net Income ($ mil.) 163.4 156.6 131.5
Diluted EPS (Net Income) 1.36 1.32 0.41
More Pharmaceutical Product Development financial information

Pharmaceutical Product Development Quarterly Statements

  Quarter Ending Jun 08 Quarter Ending Mar 08 Quarter Ending Dec 07
Revenue ($ mil.) 407.0 396.3 375.0
Gross Profit ($ mil.) 188.7 187.7 169.1
Operating Income ($ mil.) 70.7 67.9 56.0
Total Net Income ($ mil.) 49.0 40.1 40.5
Diluted EPS (Net Income) 0.41 0.33 0.33
More Pharmaceutical Product Development financial information

Pharmaceutical Product Development Stock Quote & Chart

12/02/08 11:00:41 EST • NASDAQ • 25.28 • Increased by +0.7300 • Increased by +2.9735 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Pharmaceutical Product Development Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 3.27 1.42 1.55
Price/Earnings Ratio 29.92 21.12 15.69
Price/Book Ratio 4.11 2.86 1.50
Price/Cash Flow Ratio 15.74 14.00 9.64
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Pharmaceutical Product Development Financial Ratios

Pharmaceutical Product Development Competitive Intelligence

Covance PAREXEL Quintiles Transnational
Annual Sales ($ mil.) 1,631.5 918.1 2,530.0
Employees 8,700 -- 18,000
Market Cap ($ mil.) 6,111.9 1,861.1 --

Competitive Landscape